Atara Biotherapeutics, Inc. (ATRA) Earnings History
Net Loss14 years of earnings data (2012–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Atara Biotherapeutics, Inc. (ATRA) Earnings Overview
As of July 8, 2026, Atara Biotherapeutics, Inc. (ATRA) reported trailing twelve-month net income of -$9M, reflecting +122.5% year-over-year growth. The company earned $-0.67 per diluted share over the past four quarters, with a net profit margin of 27.1%.
Looking at the long-term picture, ATRA's historical earnings data spans multiple years. The company achieved its highest annual net income of $33M in fiscal 2025, representing a new all-time high.
Atara Biotherapeutics, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including FATE (-$130M net income, -2051.1% margin), ADCT (-$137M net income, -175.3% margin), CABA (-$175M net income), ATRA has outperformed on profitability metrics. Compare ATRA vs FATE →
ATRA Earnings vs Peers
Earnings metrics vs comparable public companies
ATRA Historical Earnings Data (2012–2025)
14 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $33M | +138.3% | $36M | $2.57 | 27.1% | 29.7% |
| 2024 | -$85M | +69.1% | -$83M | $-11.41 | -66.2% | -64.7% |
| 2023 | -$276M | -20.9% | -$276M | $-65.18 | -3220.9% | -3219.5% |
| 2022 | -$228M | +32.9% | -$281M | $-55.96 | -359.1% | -441.2% |
| 2021 | -$340M | -10.9% | -$340M | $-90.78 | -1672.3% | -1673.9% |
| 2020 | -$307M | -5.4% | -$309M | $-103.63 | - | - |
| 2019 | -$291M | +87.4% | -$296M | $-141.78 | - | - |
| 2018 | -$2.31B | -93.1% | -$237M | $-131.64 | - | - |
| 2017 | -$1.19B | -51.2% | -$122M | $-100.03 | - | - |
| 2016 | -$790M | -38.1% | -$81M | $-68.78 | - | - |
| 2015 | -$572M | -104.3% | -$58M | $-55.92 | - | - |
| 2014 | -$280M | -219.2% | -$28M | $-140.42 | - | - |
| 2013 | -$88M | +28.8% | -$9M | $-227.09 | - | - |
| 2012 | -$123M | - | -$3M | $-16.81 | - | - |
Download Data
Export ATRA earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
14+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ATRA — Frequently Asked Questions
Quick answers to the most common questions about buying ATRA stock.
What is ATRA earnings per share (EPS)?
ATRA trailing twelve-month (TTM) diluted EPS is $-0.67, reflecting +122.5% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2012 to 2025 is available in the table on this page.
What is Atara Biotherapeutics, Inc.'s net income?
Atara Biotherapeutics, Inc. (ATRA) trailing twelve-month net income is $-9M as of 2025. Earnings grew +122.5% year-over-year.
Is ATRA profitable?
ATRA is not currently profitable on a TTM basis, reporting a net loss of $-9M. Net margin is +27.1%. Investors should monitor for a return to profitability.
What is ATRA's earnings growth rate?
ATRA compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2012 to 2025.
What are ATRA's profit margins?
Atara Biotherapeutics, Inc. net profit margin is +27.1%, operating margin is +29.7%, and gross margin is +82.4%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is N/A.
Is ATRA growing earnings?
Yes, ATRA earnings are accelerating — EPS growth of +122.5% exceeds the 5-year CAGR of N/A. TTM net income reached $-9M. Earnings momentum is strengthening.
What was ATRA's best earnings year?
Atara Biotherapeutics, Inc.'s highest annual net income on record is $33M, achieved in fiscal year 2025. Earnings history on this page spans 2012 to 2025 and includes all annual and quarterly figures.
What were ATRA's earnings last quarter?
ATRA's most recent reported quarter was Q1 2026. Net income was $-4M with diluted EPS of $-0.29. For a full breakdown of all quarters, see the quarterly earnings table on this page.